Skip to main content

West Virginia Medical Marijuana Sales Start Delayed Until 2021 Or 2022

Two steps forward, one back

It’s interesting to contrast differing banking news that hit this week in West Virginia and Florida.

West Virginia Gov. Jim Justice signed a medical marijuana banking bill that will allow financial institutions in the state to bid on providing banking services related to the state’s MMJ program.

But SunTrust Bank in Tallahassee, Florida, revealed it was closing the account of the Medical Marijuana Business Association of Florida on April 18.

MJBizDaily takeaway: Any moves to improve cannabis banking access are welcome, but short of federal action (click here for more on that topic), banks will remain leery of taking marijuana business customers, noted Rachel Gillette, head of the cannabis practice at the Greenspoon Marder law firm.

SunTrust’s move against the Florida MMJ association “highlights the urgency” of passing a federal banking bill, Gillette said.

In a blow to businesses hoping to quickly enter the West Virginia medical marijuana market, it could take up to three years before the new cannabis program is launched, a state official confirmed to Marijuana Business Daily.

Allison Adler, director of communications for the West Virginia Department of Health, wrote in an email to MJBizDaily  that the “primary cause” behind the projected two-to-three year delay is concern over the ability of MMJ companies to secure banking services. The banking issue was addressed in recent legislation.

The state treasurer, Adler noted, recently issued a request for proposals from financial institutions interested in providing banking services to the industry. However, the proposals will “require time to evaluate and implement.”

Adler continued that “it is important to note that after a solution to the current banking issue is found, it will take time for multiple stages of the medical cannabis permitting process to be implemented.”

The whole process, she added, also requires program staffing and development, rules implementation, and registration of medical providers and patients.

Advance work already undertaken by the state should shorten this timeline, according to Adler. Still, her office  estimates it will take two to three years after a fix to the banking issue before dispensaries will open.

MJBizDaily previously projected sales would start sometime in 2020.

When West Virginia’s program is up and running, it will have these business elements, according to legislation passed in May:

  • Up to 10 growers. Each grower may have up to two locations per permit.
  • Up to 10 processors.
  • Up to 100 dispensaries.

An individual or business is permitted to hold a grower, processor and dispensary permit, but one individual can’t hold more than 10 dispensary permits.

Before a permit is issued, the applicant must get written approval from the board of health in the county where the business is going to be located.

Original Article Source: https://mjbizdaily.com/west-virginia-medical-marijuana-sales-start-delayed-until-2021-or-2022/

Comments

Popular posts from this blog

New York City Adds More Exceptions To Pre-Employment Marijuana Testing Ban

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the subs

Charlotte Figi The Girl Who Inspired A CBD Movement Has Died At Age 13

Charlotte had recently been hospitalized due to pneumonia, breathing problems and seizures. She was treated as a likely case of Covid-19, her mother, Paige Figi, said Wednesday, although she tested negative for the virus. “Charlotte is no longer suffering. She is seizure-free forever,” a family friend wrote on Paige Figi’s Facebook page, announcing Charlotte’s death. “Thank you so much for all of your love.” Charlotte became a symbol of the possibilities of CBD after CNN Chief Medical Correspondent Dr. Sanjay Gupta told her story in the documentary “Weed.” In the film, Charlotte was shown to be a playful child who was overcome by horrific seizures, which were quelled with Charlotte’s Web, a marijuana strain named in her honor. Charlotte had Dravet syndrome, a rare form of epilepsy which was not controlled by medication. The Stanley brothers, marijuana growers in Colorado, were crossbreeding a strain of marijuana high in CBD and low in THC, its psychoactive ingredient. After Charlo

Virginia CBD Program Criticized As Multistate Medical Cannabis Operators Gain Edge

Seven companies are challenging a CBD licensing process in Virginia that resulted in multistate medical marijuana operators getting a majority of available licenses. The appeals called the process “wildly prejudicial.” Out of 51 applicants for five vertically integrated CBD and THC-A licenses, multistate operators received three, a situation that spurred the appeals, The Virginian-Pilot reported. Applicants filing the appeals complained the closed-meeting review process lacked fairness and transparency. One consultant to an applicant said the selections felt “predetermined.” The Virginia Board of Pharmacy reportedly sent information to the applicants in December explaining its selections, but some applicants weren’t satisfied. A board spokeswoman wrote in an email to the Pilot that the board “does not comment on pending litigation.” The five winning applicants , called “pharmaceutical processors,” have a year from winning the licenses to become operational. The multistate